World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 13 January 2015
Main ID:  ISRCTN22302839
Date of registration: 20/08/2014
Prospective Registration: No
Primary sponsor: Atrium Medical Centre (Atrium Medisch Centrum) (Netherlands)
Public title: Effects of compressive bandages following stripping of greater saphenous vein (GSV) (EFFecten van COMpressief DRukverband na Varices OPeratie)
Scientific title: Effects of compressive bandages following stripping of GSV
Date of first enrolment: 24/02/2010
Target sample size: 100
Recruitment status: Completed
URL:  http://isrctn.com/ISRCTN22302839
Study type:  Interventional
Study design:  Prospective randomised controlled trial (Treatment)  
Phase: 
Countries of recruitment
Netherlands
Contacts
Name: TA    Sigterman
Address:  Hoograamstraat 113 6211BJ maastricht Netherlands
Telephone:
Email:
Affiliation: 
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: 1. Primary insufficiency of GSV (CEAP classification; C2 en C3)
2. Unilateral crossectomy and strip of GSV
3. Bilateral crossectomy and strip of GSV

Exclusion criteria: 1. CEAP classification C5-C6
2. Non-compliance with postoperative compressive therapy


Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Venous insufficiency
Circulatory System
Venous insufficiency (chronic)(peripheral)
Intervention(s)
Randomization of subjects with the aid of a computer performed randomisation list generated. Randomization works with a block size of 8 subjects to promote equal distribution of numbers of patients on the two treatment groups. All patients gave written consent to participate in the study.

Study population:
The study population will consist of two groups:
1. The group of 50 patients who receive postoperative compressive bandages for 4 hours (intervention group).
2. A group of 50 patients who receive postoperative compressive bandages for 72 hours (control group).

Follow-up:
Patients were seen day 3 and day 14 postoperative for primary and secondary outcomes.
Primary Outcome(s)
The primary endpoint is edema of the leg, objectified by volume measurements at day 14 post-operative, performed by the investigator. A Perometer® (Bösl Medizintechnik, Aachen- Deutschland) will be used. This leg volume measurement will be performed on three standardized points on the leg: 10 cm above the upper edge of the patella, at the tuberosity of the tibia and 5 cm below the tuberosity of the tibia
Secondary Outcome(s)
1. Post-operative pain will be scored by the patient on a standardized Visual Analogue Scale (VAS) from 1 to 10.
2. Postoperative complications such as subcutaneous hematoma formation, thrombophlebitis and postoperative swelling will be documented.
3. Time to full recovery and quality of life are secondary endpoints. The HRQOL will be estimated by the SF-36 questionnaire, which will be asked to fill in at randomization and after 2 weeks. At this point the patient will also be asked to determine the time in days to full recovery after the surgery.
Secondary ID(s)
09-T-76
Source(s) of Monetary Support
Investigator initiated and funded
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history